These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17395662)

  • 1. Long-term application of lepirudin on chronic haemodialysis over 34 months after heparin-induced thrombocytopenia.
    Gay BE; Räz HR; Schmid HR; Beer JH
    Nephrol Dial Transplant; 2007 Jun; 22(6):1790-1. PubMed ID: 17395662
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of lepirudin in haemodialysis complicated with heparin-induced thrombocytopenia type II (HIT II)--dosage monitoring.
    Kassimatis TI; Apostolou T; Theodoridis T; El Ali M; Hadjiconstantinou V
    Nephrol Dial Transplant; 2006 Nov; 21(11):3341-2. PubMed ID: 16822790
    [No Abstract]   [Full Text] [Related]  

  • 3. Lepirudin for cardiopulmonary bypass surgery in a patient with terminal renal insufficiency and acute heparin-induced thrombocytopenia.
    Riess FC; Dobritzsch B; Kormann J
    Thorac Cardiovasc Surg; 2006 Mar; 54(2):140-2. PubMed ID: 16541359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient.
    Nowak G; Bucha E; Brauns I; Czerwinski R
    Wien Klin Wochenschr; 1997 May; 109(10):354-8. PubMed ID: 9200807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lepirudin for heparin-induced thrombocytopenia.
    Med Lett Drugs Ther; 1998 Sep; 40(1036):94-5. PubMed ID: 9774965
    [No Abstract]   [Full Text] [Related]  

  • 6. Extremely low doses of lepirudin in a patient with heparin-induced thrombocytopenia, high bleeding risk and renal insufficiency.
    Tardy-Poncet B; Charier D; Diconne E; Zeni F; Garraud O; Tardy B; Campos L
    Br J Haematol; 2009 Aug; 146(4):456-7. PubMed ID: 19519692
    [No Abstract]   [Full Text] [Related]  

  • 7. Lepirudin for anticoagulation in patients with heparin-induced thrombocytopenia treated with continuous renal replacement therapy.
    Gajra A; Vajpayee N; Smith A; Poiesz BJ; Narsipur S
    Am J Hematol; 2007 May; 82(5):391-3. PubMed ID: 17109386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hirudins in the treatment of heparin-induced thrombocytopenia and in thrombosis prophylaxis].
    Lubenow N; Greinacher A
    Hamostaseologie; 2002 Aug; 22(3):44-54. PubMed ID: 12215761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous lepirudin for heparin-induced thrombocytopenia and when other anticoagulants fail: illustrative cases.
    Deitcher SR; Ngengwe R; Kaplan R; Liebman H; Kaplan K; Blinder M
    Clin Adv Hematol Oncol; 2004 Jun; 2(6):382-4; discussion 384-6. PubMed ID: 16163209
    [No Abstract]   [Full Text] [Related]  

  • 10. Lepirudin: a bivalent direct thrombin inhibitor for anticoagulation therapy.
    Greinacher A
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):339-57. PubMed ID: 15151481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lepirudin is a safe and effective anticoagulant for patients with heparin-associated antiplatelet antibodies.
    Mudaliar JH; Liem TK; Nichols WK; Spadone DP; Silver D
    J Vasc Surg; 2001 Jul; 34(1):17-20. PubMed ID: 11436069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
    Dang CH; Durkalski VL; Nappi JM
    Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Argatroban and lepirudin requirements in a 6-year-old patient with heparin-induced thrombocytopenia.
    John TE; Hallisey RK
    Pharmacotherapy; 2005 Oct; 25(10):1383-8. PubMed ID: 16185183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lepirudin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation.
    Dager WE; Gosselin RC; Yoshikawa R; Owings JT
    Ann Pharmacother; 2004 Apr; 38(4):598-601. PubMed ID: 14982973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bidirectional glenn shunt surgery using lepirudin anticoagulation in an infant with heparin-induced thrombocytopenia with thrombosis.
    Iannoli ED; Eaton MP; Shapiro JR
    Anesth Analg; 2005 Jul; 101(1):74-6, table of contents. PubMed ID: 15976209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination platelet glycoprotein IIb/IIIa receptor and lepirudin administration during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
    Pinto DS; Sperling RT; Tu TM; Cohen DJ; Carrozza JP
    Catheter Cardiovasc Interv; 2003 Jan; 58(1):65-8. PubMed ID: 12508198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of ecarin clotting time (ECT) with lepirudin therapy in heparin-induced thrombocytopenia and cardiopulmonary bypass.
    Fabrizio MC
    J Extra Corpor Technol; 2001 May; 33(2):117-25. PubMed ID: 11467439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term citrate anticoagulation for high-flux haemodialysis in a patient with heparin-induced thrombocytopenia type II.
    Unver B; Sunder-Plassmann G; Hörl WH; Apsner R
    Acta Med Austriaca; 2002; 29(4):146-8. PubMed ID: 12424942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bivalirudine in heparin-induced thrombocytopenia].
    Gasol-Boncompte M; Gracia-García B; Pastó-Cardona L; Jódar-Masanes R
    Farm Hosp; 2009; 33(5):285-6. PubMed ID: 19775579
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.
    Kiser TH; Jung R; MacLaren R; Fish DN
    Pharmacotherapy; 2005 Dec; 25(12):1736-45. PubMed ID: 16305293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.